DNDT’s core competencies include acquiring or taking strategic financial positions in cutting-edge companies that have synergies in business-to-business and business-to-consumer products, and new technology opportunities that are targeted to resolving unmet consumer needs and emergent business domains.
Structural Dynamics is DNDT’s primary analytical tool for corporate acquisition/investment strategy. This strategy includes scenario planning and some aspects of systems thinking to consider that many factors may sometimes combine in complex ways to create unexpected futures. This method allows DNDT strategic analysis personnel to include factors that are difficult to formalize, such as novel insights about the future, possible changes in values, or unanticipated regulations or inventions. This allows us to consider a wide range of possible developments or strategic alternatives, choose a desirable course of action, monitor global developments, and, if necessary, make timely strategic adjustments
Best Balms Corporation, www.bestbalms.com, the third largest all natural specialty balm company in the United States, is a wholly owned subsidiary of DND Technologies.
Best Balms Announces Better Than Expected Earnings For The 1st Quarter of 2012. This is our best quarter yet!!!
Best Balms Corporation is currently the fastest growing specialty balm/health care company in the United States for the third year in a row. Our growth has been the result of a fantastic all natural product line that is very reasonably priced.
Best Balms Corporation has announced the introduction of two liquid holistic products for maximum pain relief & itch relief. Both products will be 100% all natural and will be packaged in specialized micro mist spray bottles. The respective names are presently being reviewed by the Office of Trademarks. Production should begin by Fall/2012 and should be available for sale in December/ 2012
What's Coming For DNDT
DNDT remained unfiled for almost 2 years.
Recently they have filed 10Q 2012 which includes balance sheet statements for 2011 & 2012.
"Stop Sign" has been removed recently and DNDT has become OTC Pink Current.
*Thinly traded stock
*Most of the O/S are in cert form.
*DTC actual float only 6.5M as per company rep
*No dilution whatsoever.
*No toxic financing
*No history of RS
*Strong management team
*Cash flow positive and already profitable from current subsidiary business.
Filings coming in...
Expected couple of huge acquisitions announcements soon....
*Possible New Business combinations, products, endorsements, trademarks
*B Stephen Bailey possibly working behind the acquisitions. He is the advisor for DNDT and CEO of JAQC. JAQC is getting merged with Rafarma soon. Rafarma is under final stage of construction and going to be the largest pharma plant in Russia.
See more DD on Rafarma.
DNDT is actively engaged in the process of updating all financials & SOS in order to accomplish couple of big acquisitions. DNDT on the ball here, Co sure is positioning itself and will be getting the word out. They are back and in a big way....
I have my tickets for big picture.
My opinion only.
Buy or sell on your own decision.
DND Technologies Inc. (DNDT)
Stock Trading Info: